Overview

A class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) and certain of the Company’s former senior executive officers alleging violations of the federal securities laws.  The Company’s common stock trades on the NASDAQ exchange under the symbol “ZYXI.”

The Zynex class action lawsuit was brought on behalf of all persons and entities who purchased or otherwise acquired Zynex securities between March 13, 2023, and March 11, 2025, both dates inclusive (the “Class Period”).

Zynex is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management and physical rehabilitation.  The Company’s products are small, battery powered electronic devices which deliver electric pulses via wires and electrode pads.

The Zynex class action lawsuit alleges that Defendants, throughout the Class Period, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants failed to disclose to investors that: (1) Zynex shipped products, including electrodes, in excess of need; (2) as a result of this practice, the Company inflated its revenue; (3) the Company’s practice of filing false claims drew scrutiny from insurers, including Tricare; (4) as a result, it was reasonably likely that Zynex would face adverse consequences, including removal from insurer networks and penalties from the federal government; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis

*          *          *

If you purchased or otherwise acquired Zynex securities between March 13, 2023, and March 11, 2025, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as lead plaintiff in the Zynex class action lawsuit is May 19, 2025.